New pill could boost testosterone in men with kidney disease

NCT ID NCT05249634

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests an oral testosterone pill called JATENZO in 20 men who have both low testosterone and chronic kidney disease. The goal is to see if the pill can raise testosterone levels and improve red blood cell counts, muscle strength, lean body mass, and sexual function. Participants take the pill daily for several weeks, and researchers monitor their blood and overall health.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
JATENZO (oral testosterone)
What this could lead to
If successful, this could offer a convenient oral treatment option for low testosterone in men with chronic kidney disease, potentially improving energy, muscle strength, and sexual function.
What could go wrong
This is a small, early-phase study with only 20 participants, so results may not apply to everyone. Oral testosterone may have side effects like liver strain or blood pressure changes, and it is not a cure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPOGONADISM, MALE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Saint Louis Univeristy

    RECRUITING

    St Louis, Missouri, 63104, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.